loading...| Preferred Name | dexmedetomidine hydrochloride | |
| Synonyms |
Precedex |
|
| Definitions |
The hydrochloride salt form of dexmedetomidine, an imidazole derivate and active d-isomer of medetomidine with analgesic, anxiolytic and sedative activities. Dexmedetomidine selectively binds to and activates presynaptic alpha-2 adrenoceptors located in the brain, thereby inhibiting the release of norepinephrine from synaptic vesicles. This leads to an inhibition of postsynaptic activation of adrenoceptors, which inhibits sympathetic activity, thereby leading to analgesia, sedation and anxiolysis. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C72738" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C72738" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000632933 |
|
| altLabel |
Precedex |
|
| CAS Registry |
145108-58-3 |
|
| cui |
C0752310 C0876757 |
|
| DATE FIRST PUBLISHED |
2009-01-14 |
|
| Date last modified |
2015-10-19 |
|
| definition |
The hydrochloride salt form of dexmedetomidine, an imidazole derivate and active d-isomer of medetomidine with analgesic, anxiolytic and sedative activities. Dexmedetomidine selectively binds to and activates presynaptic alpha-2 adrenoceptors located in the brain, thereby inhibiting the release of norepinephrine from synaptic vesicles. This leads to an inhibition of postsynaptic activation of adrenoceptors, which inhibits sympathetic activity, thereby leading to analgesia, sedation and anxiolysis. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C72738" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C72738" NCI Thesaurus) |
|
| LT |
TRD |
|
| NCI ID |
C72738 |
|
| notation |
CDR0000632933 |
|
| ORIG STY |
Drug/agent |
|
| prefLabel |
dexmedetomidine hydrochloride |
|
| tui |
T109 T121 |